Program: "The Role of Atypical Antipsychotic Long-Acting Therapies in the Treatment and Maintenance Treatment of Bipolar I Disorder" -- David Jahn, MD, Staff Psychiatrist and Clinical Assistant Professor of Psychiatry, Zepf Center and University of Toledo Medical Center.  Sponsored by Anne Moran, Janssen Pharmaceuticals, 419 810-5105.  RSVP by Thursday, May 3, to your Janssen representative, or http://www.medforcereg.net/SOMP28988.